首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >The IAEA/WHO TLD postal dose quality audits for radiotherapy: a perspective of dosimetry practices at hospitals in developing countries.
【24h】

The IAEA/WHO TLD postal dose quality audits for radiotherapy: a perspective of dosimetry practices at hospitals in developing countries.

机译:IAEA / WHO TLD放射治疗邮政剂量质量审核:发展中国家医院剂量学实践的观点。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: The IAEA/WHO TLD postal programme for external audits of the calibration of high-energy photon beams used in radiotherapy has been in operation since 1969. This work presents a survey of the 1317 TLD audits carried out during 1998-2001. The TLD results are discussed from the perspective of the dosimetry practices in hospitals in developing countries, based on the information provided by the participants in their TLD data sheets. MATERIALS AND METHODS: A detailed analysis of the TLD data sheets is systematically performed at the IAEA. It helps to trace the source of any discrepancy between the TLD measured dose and the user stated dose, and also provides information on equipment, dosimetry procedures and the use of codes of practice in the countries participating in the IAEA/WHO TLD audits. RESULT: The TLD results are within the 5% acceptance limit for 84% of the participants. The results for accelerator beams are typically better than for Co-60 units. Approximately 75% of participants reported dosimetry data, including details on their procedure for dose determination from ionisation chamber measurements. For the remaining 25% of hospitals, who did not submit these data, the results are poorer than the global TLD results. Most hospitals have Farmer type ionisation chambers calibrated in terms of air kerma by a standards laboratory. Less than 10% of the hospitals use new codes of practice based on standards of absorbed dose to water. CONCLUSION: Despite the differences in dosimetry equipment, traceability to different standards laboratories and uncertainties arising from the use of various dosimetry codes of practice, the determination of absorbed dose to water for photon beams typically agrees within 2% among hospitals. Correct implementation of any of the dosimetry protocols should ensure that significant errors in dosimetry are avoided.
机译:背景与目的:自1969年以来,IAEA / WHO TLD邮政计划就对放射治疗中使用的高能光子束进行了外部审核,该计划已开始实施。这项工作是对1998-2001年进行的1317次TLD审核的调查。基于参与者在其TLD数据表中提供的信息,从发展中国家医院剂量学实践的角度讨论了TLD结果。材料和方法:国际原子能机构对TLD数据表进行了详细的分析。它有助于追踪TLD测量剂量与用户指定剂量之间任何差异的根源,并提供有关设备,剂量测定程序以及参与IAEA / WHO TLD审核的国家/地区的实践准则的信息。结果:TLD结果在84%的参与者的5%接受极限之内。加速器光束的结果通常优于Co-60单元。大约75%的参与者报告了剂量学数据,包括有关通过电离室测量确定剂量的程序的详细信息。对于其余25%没有提交这些数据的医院,其结果要比全球TLD结果差。大多数医院都设有标准实验室根据空气比释动能校准的农夫型电离室。不到10%的医院根据对水的吸收剂量标准使用新的操作规范。结论:尽管剂量学设备存在差异,可追溯至不同标准实验室,并且由于使用各种剂量学操作规范而产生不确定性,但医院中光子束对水吸收剂量的确定通常在2%之内。正确执行任何剂量学协议,应确保避免剂量学上的重大错误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号